Published on in Vol 5, No 1 (2022): Jan-Mar
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/33391, first published
.

Journals
- O'Connor C, Byrne B, Roche D, O'Connell G, O'Connell M, Murphy M, Bourke J, Lynch M, Bennett M. Biological and JAK inhibitor therapy outcomes for severe psoriasis in trisomy 21. The Journal of Dermatology 2023;50(10):1339 View
- Kudsi M, Haj Ali D, Khalayli N, Jaber S, Almasri R. Systemic lupus erythematosus and Down syndrome: a case report and literature review. Annals of Medicine & Surgery 2024;86(2):1112 View
- Szybiak-Skora W, Cyna W, Lacka K. Autoimmune Thyroid Disease in Patients with Down Syndrome—Review. International Journal of Molecular Sciences 2024;26(1):29 View
- Łanocha M, Polak K, Bergler-Czop B. Terra firma-forme dermatosis in a patient with trisomy 21: Dermoscopic and ultraviolet-induced fluorescence dermatoscopy observations. Dermatologica Sinica 2025 View